Skip to content
Home/Companies/Biotech/AvenCell

AvenCell

Biotech·United States·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns AvenCell?

AvenCell is an American Biotech company, currently owned by Novo Holdings since 2024.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Novo Holdings
Investor
Novo Holdings
Novo Holdings Growth Investments · 1999 · Growth

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Novo Holdings Growth Investments

Other portfolio companies in the same fund.

Surya Hospitals
Active
HealthcareIndia· 2026
Phasecraft
Phasecraft
Active
Deep TechUK· 2025
Cleveland Diagnostics
Active
MedTechUS· 2024
Convergent
Active
BiotechUS· 2024
Medi Assist
Active
HealthTechIndia· 2024
Nalu Medical
Exited 2026
MedTechUS· 2024
to Boston Scientific

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns AvenCell?

AvenCell is currently owned by Novo Holdings, through Novo Holdings Growth Investments, since 2024.

When did Novo Holdings acquire AvenCell?

Novo Holdings acquired AvenCell in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue